Clinical Trial

Protest Trial: TXA vs Saline

Enrolling by Invitation Phase 3
View on ClinicalTrials.gov →
Summary
To determine if endobronchial (topical) tranexamic acid used prophylactically prior to performing transbronchial biopsies in lung transplant recipients reduces bleeding risk.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-06-30 -> 2026-12-30 2026-07-22
minor Completion pushed: 2027-06-30 -> 2027-12-30 2026-07-22
Trial Details
NCT Number NCT06422273
Lead Sponsor Corewell Health West
Conditions Lung Transplant, Complications Surgical
Enrollment 94 participants
Start Date 2024-04-16
Primary Completion 2026-12-30 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-21